Hemophilia and Related Bleeding Disorders Feeds

Age-Related Morbidities

How I Treat Age-Related Morbidities in Elderly Persons With Hemophilia

Pier M. Mannucci, Roger E. G. Schutgens, Elena Santagostino, Evelien P. Mauser-Bunschoten

Age-Related Morbidities

Emerging Clinical Concerns in the Ageing Haemophilia Patient

B. A. Konkle, C. Kessler, L. Aledort, J. Andersen, P. Fogarty, P. Kouides, D. Quon, M. Ragni, A. Zakarija, B. E. Wenstein

Which Patients Should Be Placed on Prophylactic Therapy?

Devising a Best Practice Approach to Prophylaxis in Boys With Severe Haemophilia: Evaluation of Current Treatment Strategies

M. Carcao, H. Chambost, R. Ljung

Which Patients Should Be Placed on Prophylactic Therapy?

Prophylaxis in Haemophilia With Inhibitors: Update From International Experience

M. Carcao, T. Lambert

Which Patients Should Be Placed on Prophylactic Therapy?

Venous Access in Haemophilic Children: Choice and Management

E. Santagostino, M. E. Mancuso

Advances in Hemophilia

Advances in Hemophilia: Experimental Aspects and Therapy

Nidra I. Rodriguez, W. Keith Hoots

Multidisciplinary Approach to the Challenge of Hemostasis

Multidisciplinary Approach to the Challenge of Hemostasis

Jerrold H. Levy, Richard P. Dutton, J. Claude Hemphill III, Aryeh Shander, David Cooper, Michael J. Paidas, Craig M. Kessler, John B. Holcomb, Jeffrey H. Lawson; Hemostasis Summit Participants

Inhibitor Development in Black Patients With Hemophilia A

The Role of Immune-Response Gene Variants in Inhibitor Development in Black Patients With Hemophilia A

Tom E. Howard, Shelley A. Cole, Carol K. Kasper, Afshin Ameri, Kavita Natarajan, Raymond G. Watts, Valrie A. Manard, Shelley M. Nakaya, Christine L. Kempton, Martina Kennedy, Benjamin Kim, Rathi V. Iyer, Laura Almasy

Measuring Adherence to Prophylactic Regimens in Hemophilia

VERITAS-Pro: A New Measure of Adherence to Prophylaxis Regimens in Hemophilia

N. Duncan, W. Kronenberger, C. Roberson, A. Shapiro

Measuring Adherence to Episodic Treatment Regimens in Bleeding Disorders

VERITAS-PRN: A New Measure of Adherence to Episodic Treatment in Bleeding Disorders

N. Duncan, W. Kronenberger, C. Roberson, A. Shapiro

Treatment of Inhibitor Bleeding – Timing is Everything

The Value of Early Treatment in Patients With Haemophilia and Inhibitors

Kavakli K, Yesilipek A, Antmen B, Aksu S, Balkan C, Yilmaz D, Kupesiz A, Sasmaz I, Lindgren P, Mesterton J

Treatment of Inhibitor Bleeding – Timing is Everything

The Need for Speed in the Management of Haemophilia Patients With Inhibitors

Salek SZ, Benson GM, Elezovic I, Krenn V, Ljung RCR, Morfini M, Remor E, Santagostino E, Sørensen B

Recombinant Factor VIII Concentrates and Inhibitor Development Risk

Rate of Inhibitor Development in Previously Untreated Hemophilia A Patients Treated With Plasma-Derived or Recombinant Factor VIII Concentrates: A Systematic Review

Iorio A, Halimeh S, Holzhauer S, Goldenberg N, Marchesini E, Marcucci M, Young G, Bidlingmaier C, Brandao LR, Ettingshausen CE, Gringeri A, Kenet G, Knöfler R, Kreuz W, Kurnik K, Manner D, Santagostino E, Mannucci PM, Nowak-Göttl U

Bypassing Agents, Immune Tolerance Induction, and Prophylaxis in Inhibitor Patients

Clinical Issues in Inhibitors

Astermark J, Santagostino E, Hoots WK

Intensive Factor VIII Treatment and Inhibitor Development in Non-Severe Hemophilia A Patients

In Non-Severe Hemophilia A the Risk of Inhibitor After Intensive Factor Treatment Is Greater in Older Patients: A Case-Control Study

Kempton CL, Soucie JM, Miller CH, Hooper C, Escobar MA, Cohen AJ, Key NS, Thompson AR, Abshire TC

The Challenges Associated With an Aging Hemophilic Population

The Challenge of an Ageing Haemophilic Population

Dolan G

Mortality in Mice With a Very Low Protein C Condition

An Accompanying Genetic Severe Deficiency of Tissue Factor Protects Mice With a Protein C Deficiency From Lethal Endotoxemia

Castellino FJ, Donahue DL, Navari RM, Ploplis VA, Walsh M

The Frequency of Moderate to Severe Allergic Reactions to Factor IX in Haemophilia B Patients

A Retrospective Study to Describe the Incidence of Moderate to Severe Allergic Reactions to Factor IX in Subjects With Haemophilia B

Recht M, Pollmann H, Tagliaferri A, Musso R, Janco R, Neuman WR

Clinical Effectiveness of Radiosynovectomy in Patients With Hemophilia

Radiosynovectomy in Hemophilia: Quantification of its Effectiveness Through the Assessment of 10 Articular Parameters

De La Corte-Rodriguez H, Rodriguez-Merchan EC, Jimenez-Yuste V

The Nature of Factor VIIa Binding and Activity, and the Regulation of Procoagulant Activity

Platelet Binding and Activity of a Factor VIIa Variant With Enhanced Tissue Factor Independent Activity

Hoffman M, Volovyk Z, Persson E, Gabriel DA, Ezban M, Monroe DM

Immune Tolerance Induction in 31 Children With Haemophilia A

Immune Tolerance Induction in 31 Children With Haemophilia A: Is ITI Less Successful in African Americans?

Callaghan MU, Rajpurkar M, Chitlur M, Warrier I, Lusher J

Blood Component Therapy in Trauma Guided With the Utilization of the Perfusionist and Thromboelastography

Blood Component Therapy in Trauma Guided With the Utilization of the Perfusionist and Thromboelastography

Walsh M, Thomas SG, Howard JC, Evans E, Guyer K, Medvecz A, Swearingen A, Navari RM, Ploplis V, Castellino FJ